 |
3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Diffuse Large B-cell Lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2016-09-19 00:00:00 |
| Sponsor | Celgene Corporation;400 Connell Drive, Suite 7000;Berkeley Heights, New Jersey, 07922 |
